Tag: BioNTech Cell & Gene Therapies GmbH

Home / BioNTech Cell & Gene Therapies GmbH

Categories

New CAR T-cell therapy showed acceptable safety profile in solid tumors

April 2022: According to preliminary data from a phase I/II clinical trial that was presented during the AACR Annual Meeting 2022, which was held from April 8-13, a new chimeric antigen receptor (CAR...
biontech-cell-gene-therapies-gmbh

Scan the code